Concepedia

Reiko Yamagishi

RY

20

Publications

600

Citations

16

H-Index

2004

Active since

Affiliations

The University of Tokyo(Current)

Senju Pharmaceutical (Japan)

University of Tokyo Hospital

National Hospital Organization

Japan Science and Technology Agency

Reiko Yamagishi is an author at The University of Tokyo specializing in ophthalmology, medicine, and cell death.

ORCID

Top concepts

Publications per year

2004–2024

20

Publications

20

Activation of the Prostanoid FP Receptor Inhibits Adipogenesis Leading to Deepening of the Upper Eyelid Sulcus in Prostaglandin-Associated Periorbitopathy

Y. Taketani, Reiko Yamagishi, Takashi Fujishiro et al. · Investigative Ophthalmology & Visual Science · 2014 · 77 citations

Neuroprotective effects of prostaglandin analogues on retinal ganglion cell death independent of intraocular pressure reduction

Reiko Yamagishi, Makoto Aihara, Makoto Araie · Experimental Eye Research · 2011 · 52 citations

, , +10

Neuroprotective effect of astaxanthin against rat retinal ganglion cell death under various stresses that induce apoptosis and necrosis.

Reiko Yamagishi, Makoto Aihara · PubMed · 2014 · 49 citations

Atria Selective Prolongation by NIP-142, an Antiarrhythmic Agent, of Refractory Period and Action Potential Duration in Guinea Pig Myocardium

Tomoyuki Matsuda, Kentaro Takeda, Mie Ito et al. · Journal of Pharmacological Sciences · 2005 · 47 citations · Full text

Mechanical stretch induces Ca2+ influx and extracellular release of PGE2 through Piezo1 activation in trabecular meshwork cells

Takatoshi Uchida, Shota Shimizu, Reiko Yamagishi et al. · Scientific Reports · 2021 · 40 citations · Full text

Rows per page

1–5 of 20